| |
Elizabeth Ratchford, M.D.
|
| | |
| | Kathleen M. Citro, R.N. |
| | |
| | 410-955-5897 |
| | |
| | eratchf1@jhmi.edu |
| | |
| | CLEVER Trial |
| | |
| | CLaudication: Exercise Versus Endoluminal Revascularization (CLEVER) |
| | |
| | NA_00015857 |
| | |
| | National Institutes of Health / National Heart, Lung, and Blood Institute |
| | |
| | CLEVER is a prospective, randomized, multicenter clinical trial designed to determine optimal treatment for claudication due to aortoiliac disease. It compares the benefits of supervised exercise, endovascular revascularization, and optimal medical care. |
| | |
| | Age 40 and older with intermittent claudication due to aortoiliac peripheral arterial disease |
| | |
| | Inability to exercise on a treadmill; allergy to cilostazol or intravenous contrast; congestive heart failure; other exclusions may apply |
| | |
| | The Johns Hopkins Hospital, 600 N. Wolfe Street Baltimore, MD 21287; Johns Hopkins at Green Spring Station, 10755 Falls Road, Lutherville, MD 21093 |
| | |
| | Transportation is reimbursed; subjects randomly assigned to exercise will be compensated for sessions attended. |
| | |
| | 5/2008 |
| | |
| | 1/2010 |
